Your browser doesn't support javascript.
loading
Recurrent CDKN1B (p27) mutations in hairy cell leukemia.
Dietrich, Sascha; Hüllein, Jennifer; Lee, Stanley Chun-Wei; Hutter, Barbara; Gonzalez, David; Jayne, Sandrine; Dyer, Martin J S; Oles, Malgorzata; Else, Monica; Liu, Xiyang; Slabicki, Mikolaj; Wu, Bian; Troussard, Xavier; Dürig, Jan; Andrulis, Mindaugas; Dearden, Claire; von Kalle, Christof; Granzow, Martin; Jauch, Anna; Fröhling, Stefan; Huber, Wolfgang; Meggendorfer, Manja; Haferlach, Torsten; Ho, Anthony D; Richter, Daniela; Brors, Benedikt; Glimm, Hanno; Matutes, Estella; Abdel Wahab, Omar; Zenz, Thorsten.
Afiliación
  • Dietrich S; Department of Medicine V, University Hospital Heidelberg, Genome Biology Unit, European Molecular Biology Laboratory, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg, Germany;
  • Hüllein J; Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg, Germany;
  • Lee SC; Human Oncology and Pathogenesis Program, Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;
  • Hutter B; Division Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany;
  • Gonzalez D; Centre for Molecular Pathology, Royal Marsden NHS Foundation Trust, London, United Kingdom;
  • Jayne S; Ernest and Helen Scott Hematological Research Institute, University of Leicester, Leicester, United Kingdom;
  • Dyer MJ; Ernest and Helen Scott Hematological Research Institute, University of Leicester, Leicester, United Kingdom;
  • Oles M; Genome Biology Unit, European Molecular Biology Laboratory, and.
  • Else M; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom;
  • Liu X; Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg, Germany;
  • Slabicki M; Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg, Germany;
  • Wu B; Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg, Germany;
  • Troussard X; Laboratoire d'Hématologie, CHU Côte de Nacre, Caen, France;
  • Dürig J; Department of Hematology, University Hospital, Essen, Germany;
  • Andrulis M; Department of General Pathology, Institute of Pathology, University of Heidelberg, Heidelberg, Germany;
  • Dearden C; Royal Marsden Hospital, London, United Kingdom;
  • von Kalle C; Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg, Germany; Heidelberg Center for Personalized Oncology (DKFZ-HIPO), German Cancer Research Center (DKFZ), Heidelberg, Germany;
  • Granzow M; Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany; and.
  • Jauch A; Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany; and.
  • Fröhling S; Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg, Germany;
  • Huber W; Genome Biology Unit, European Molecular Biology Laboratory, and.
  • Meggendorfer M; Munich Leukemia Laboratory, Munich, Germany.
  • Haferlach T; Munich Leukemia Laboratory, Munich, Germany.
  • Ho AD; Department of Medicine V, University Hospital Heidelberg.
  • Richter D; Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg, Germany;
  • Brors B; Division Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany;
  • Glimm H; Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg, Germany;
  • Matutes E; Royal Marsden Hospital, London, United Kingdom;
  • Abdel Wahab O; Human Oncology and Pathogenesis Program, Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;
  • Zenz T; Department of Medicine V, University Hospital Heidelberg, Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center (DKFZ), Heidelberg, Germany;
Blood ; 126(8): 1005-8, 2015 Aug 20.
Article en En | MEDLINE | ID: mdl-26065650
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia de Células Pilosas / Inhibidor p27 de las Quinasas Dependientes de la Ciclina / Mutación Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Blood Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia de Células Pilosas / Inhibidor p27 de las Quinasas Dependientes de la Ciclina / Mutación Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Blood Año: 2015 Tipo del documento: Article